Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2010
03/24/2010EP2166019A2 Immunisation against Chlamydia Pneumoniae
03/24/2010EP2166016A1 Phosphoramidate Derivatives of Nucleosides
03/24/2010EP2166015A1 Lincosamide derivative, and antibacterial agent comprising the same as active ingredient
03/24/2010EP2166000A1 7-, 8- and 9-substituted tetracycline compounds
03/24/2010EP2165704A1 Use of alverine for the treatment of cutaneous affections
03/24/2010EP2164869A2 Antigen-binding proteins targeting s. aureus orf0657n
03/24/2010EP2164849A2 Pyridopyrazine derivatives, process of manufacturing and uses thereof
03/24/2010EP2164846A2 Heteroaryl substituted thiazoles and their use as antiviral agents.
03/24/2010EP2164829A1 A new peptide deformylase inhibitor compound and manufacturing process thereof
03/24/2010EP2164521A2 Glycoconjugates and use thereof as vaccine against<i>shigella flexneri</i>serotype 3a and x
03/24/2010EP2164518A1 Formulations for the oral administration of therapeutic agents and related methods
03/24/2010EP1710236B1 Derivatives of pyridine and quinoline
03/24/2010EP1067962B1 Derivatives of pneumococcal choline binding proteins for vaccines
03/24/2010CN201426857Y Amoxicillin long-acting granular pill
03/24/2010CN201426856Y Tilmicosin enteric coated granule
03/24/2010CN201426855Y Florfenicol enteric coated granule
03/24/2010CN101679517A Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
03/24/2010CN101679516A Antigen-binding proteins targeting s. aureus ORF0657
03/24/2010CN101679515A Novel human anti-r7v antibodies and uses thereof
03/24/2010CN101679513A Recombinant antibodies for treatment of respiratory syncytial virus infections
03/24/2010CN101679512A Human antibodies against hepatitis c virus (hcv) uses thereof
03/24/2010CN101679472A Compounds for preventing or treating viral infections and methods of use thereof
03/24/2010CN101679471A aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
03/24/2010CN101679454A Antimicrobial heterocyclic compounds for treatment of bacterial infections
03/24/2010CN101679442A Compounds for the treatment of hepatitis c
03/24/2010CN101679441A Compounds for the treatment of hepatitis c
03/24/2010CN101679437A cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
03/24/2010CN101679425A 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives
03/24/2010CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives
03/24/2010CN101679416A Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu
03/24/2010CN101679415A oxazolidinone antibiotics
03/24/2010CN101679414A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679325A modulators of pharmacokinetic properties of therapeutics
03/24/2010CN101679294A Non-nucleoside reverse transcriptase inhibitors
03/24/2010CN101679277A Novel peptide inhibitors of hepatitis c virus replication
03/24/2010CN101679240A p1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
03/24/2010CN101678213A Cyclic peptide cxcr4 antagonists
03/24/2010CN101678073A Methods and compositions for use of cyclic analogues of histatin
03/24/2010CN101678072A methods of treating infection
03/24/2010CN101678048A Use of isoosmotic seawater-based ionic solutions for manufacturing medical devices for the prevention of complications of the common cold or of the flu syndrome
03/24/2010CN101678040A Use of carrageenan for treating rhinovirus infections
03/24/2010CN101678028A Penciclovir for the treatment of recurrent genital herpes with a one-day application
03/24/2010CN101678015A Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis
03/24/2010CN101678004A Triazol compounds for treating biofilm formation
03/24/2010CN101677976A A method of inhibiting HIV replication
03/24/2010CN101676401A Scorpion peptide and preparation method
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
03/24/2010CN101676290A Levofloxacin salt, and preparation method thereof and medicament composition
03/24/2010CN101676284A Preparation method of nifuratel with high purity
03/24/2010CN101676279A Preparation method of zedoary cyclic diolefine
03/24/2010CN101675993A melan-a peptide analogue-virus-like-particle conjugates
03/24/2010CN101675923A New usage of zedoary cyclic diolefine
03/24/2010CN101675916A Preparation method of levo-ofloxacin hyaluronic acid gel slow-released agent
03/24/2010CN100595278C Genic engineering strain of expression recombinant prawn peptide Pen24 and its use
03/24/2010CN100595200C Compound of dehydrogenated cavidine group and application in medication
03/24/2010CN100595198C Zedoary cyclo-diolefine and its derivatives preparation method and use
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594931C The pIFN-gamma gene adjuvant for pig vaccine and its prepn process
03/24/2010CN100594930C Medicinal composition using anterior pituitary adrenal cortical extract as main component, and its preparation method and use
03/24/2010CN100594926C Anti-microbial agent and anti-microbial composition
03/24/2010CN100594921C Traditional Chinese medicine compound preparations for treating chronic hepatitis B and cirrhosis
03/24/2010CN100594911C Medicine composition and use
03/24/2010CN100594903C HCV inhibiting bi-cyclic pyrimidines
03/24/2010CN100594896C Application of zedoary root cyclic diolefine in preparing medicament for treating tumour disease
03/24/2010CN100594893C Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
03/24/2010CN100594889C Penciclovir freeze dried and method of manufacturing the same
03/24/2010CN100594888C Pharmaceutical compositions suitable for the treatment of ophthalmic diseases
03/24/2010CN100594884C Recombination human interferon injection
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683049 beta -methyl carbapenem compounds; for multiple-drug resistant bacterial strain
03/23/2010US7683038 Such as gellan, carboxymethylcellulose, pectic acid, pectin and hyaluronic acid derivativesl; for use in the pharmaceutical, biomedical, surgical and healthcare fields
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010CA2639023A1 Bioscience iii
03/23/2010CA2459928C Photodynamic porphyrin antimicrobial agents
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2389745C Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
03/23/2010CA2380951C Pharmaceutical compositions for oral and topical administration
03/23/2010CA2358457C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
03/23/2010CA2329000C Stabilised virus preparation
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2290724C Glycopeptide hexapeptides
03/23/2010CA2225388C Low pathogenicity prrs live virus vaccines and methods of preparation thereof
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2196656C Method for the preparation of (±)-calanolide a and intermediates thereof
03/23/2010CA2194797C Nucleic acid containing composition, preparation and uses of same
03/18/2010WO2010030811A2 CARBACEPHEM β-LACTAM ANTIBIOTICS
03/18/2010WO2010030810A1 Carbacephem beta-lactam antibiotics
03/18/2010WO2010030808A2 Novel antibiotics against resistant bacteria
03/18/2010WO2010030790A2 Methods and compositions for stimulation of mammalian innate immune resistance to pathogens
03/18/2010WO2010030690A1 Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs
03/18/2010WO2010030666A2 Elimination of a contaminating non-human sialic acid by metabolic competition
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010030582A2 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition
03/18/2010WO2010030182A2 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
03/18/2010WO2010030002A1 Cell capable of expressing exogenous gitr ligand
03/18/2010WO2010029562A1 Bioactive composition for the treatment of the hiv/aids, method for manufacturing and using the same
03/18/2010WO2010029313A1 Antiinfective compounds
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1798